Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 3 Recurrence 2 Pancreatic Neoplasms 2 Lymphoma, B-Cell 2 Liver Neoplasms 2 Hematologic Neoplasms 2 Sarcoma 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Metastatic Solid Tumors 1 Mesothelioma 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Hemorrhage 1 Hematologic Diseases 1 Head and Neck Neoplasms 1 Gynecological Solid Tumors 1 Fallopian Tube Neoplasms 1 Erectile Dysfunction 1 Diarrhea 1 Colitis 1 Childhood Solid Tumor 1 Carcinoma, Hepatocellular 1

Interventions

Infliximab 3 Fecal Microbiota Transplantation 3 vedolizumab 2 Prednisone 2 Methylprednisolone 2 LDP-02 2 Immunoglobulin G 2 Disulfides 2 CT-P13 2 tocilizumab 1 prednylidene 1 fish oil triglycerides 1 deltacortene 1 Standard of Care 1 Practice Guidelines as Topic 1 Methylprednisolone Hemisuccinate 1 Loperamide 1 Injections 1 Endoscopy 1 Diagnosis 1 Colonoscopy 1 Cell- and Tissue-Based Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Colitis × Cell- and Tissue-Based Therapy × Clear all

NCT02814864 2021-08-03

PRISME

Assistance Publique - Hôpitaux de Paris

Phase 2 Unknown

Colitis, Diarrhea, Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡